Flusource
Search
Why Vaccinate
Economic Burden
Updated ACIP Guidelines
Practice Support Materials
Find Distributors
Additional Resources
For Pharmacists
For Employers
For Consumers
VIP
Send to a Friend Send to a Friend
Change font sizeChange font size
For U.S.Healthcare Professionals Only
Non-U.S. residents
Novartis
Learn About Novartis

Updated ACIP Guidelines

The Centers for Disease Control (CDC) and Prevention and its Advisory Committee on Immunization Practices (ACIP) state that vaccination is recommended for people, including school-age children, who want to reduce the likelihood of becoming ill with influenza or transmitting influenza to others should they become infected.1 Vaccination is also recommended for those in high-risk groups, including:

Children and Adolescents

  • All those aged 6 to 59 months*
  • Those aged 6 months* to 18 years, who take long-term aspirin therapy. (They are at increased risk of Reyes Syndrome)

Adults and Children with Certain Medical Conditions

  • Those who have chronic disorders of the pulmonary or cardiovascular systems, including asthma (hypertension is not considered a high-risk condition) and renal, hepatic, hematological, or metabolic disorders (including diabetes mellitus)
  • Those who have immunosuppression (including immunosuppression caused by medications or by HIV)
  • Those with any condition (e.g., cognitive dysfunction, spinal cord injuries, seizure disorders, or other neuromuscular disorders) that can compromise respiratory function or the handling of respiratory secretions, or that can increase the risk of aspiration

Healthy adults

  • Women who will be pregnant during flu season
  • People aged 50 years or older

Seniors

  • Residents of nursing homes or other chronic-care facilities
Caregivers and health workers
  • People who live with or look after someone else in a high-risk group
  • Families and caregivers of children aged 0 to 59 months
  • Healthcare workers

* Influenza vaccines are not currently indicated for children less than 6 months of age.

References:

  1. CDC. Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2007:56(Early Release);1–54.
Callout
Order

2007 ACIP Guidelines
Printer-friendly version

Novartis

Influenza vaccination may not prevent the disease in 100% of individuals. Persons should consult their healthcare provider to determine if they have a condition that precludes them from receiving the vaccine. All vaccines have side effects. The most common side effects of influenza vaccines include local reactions and mild general symptoms.

Why Vaccinate? |  Economic Burden  |  Updated ACIP Guidelines  |  Practice Support Materials  |  Find Distributors|  Additional Resources

For Consumers  | For Pharmacists  |  For Employers

FluSource.com has been developed by Novartis Vaccines as part of the company's commitment to individual and public health.

Full Prescribing Information  |  Contact Us  |  Site Map

This site is sponsored by Novartis Vaccines and Diagnostics, Inc.
Use of this website is governed by the Terms of Use and Privacy Statement.
Copyright © 2008 Novartis Vaccines and Diagnostics, Inc. All rights reserved.